Sartore‐Bianchi described the identification of a novel LMNA‐NTRK1 gene fusion in a metastatic CRC patient, which was linked to sensitivity to the pan‐TRK inhibitor, entrectinib. This evidence concerns the gene TPM3 and colorectal carcinoma.